209
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

      brief-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          SARS-CoV-2 proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. 11 of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day one after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with production of IgG and IgA.

          Related collections

          Author and article information

          Journal
          Clin Infect Dis
          Clin Infect Dis
          cid
          Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
          Oxford University Press (US )
          1058-4838
          1537-6591
          20 May 2021
          20 May 2021
          : ciab465
          Affiliations
          [1 ]Department of Pathology, Brigham and Women’s Hospital, Boston , MA, USA
          [2 ]Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston , MA, USA
          [3 ]Harvard Medical School, Boston , MA, USA
          [4 ]Division of Infectious Diseases, Brigham and Women’s Hospital, Boston , MA, USA
          [5 ]Division of Infectious Diseases, Centre Hospitalier de l’Université de Montréal , Montreal, QC, Canada
          [6 ]Center for Clinical Investigation, Brigham and Women’s Hospital, Boston , MA, USA
          Author notes
          Corresponding author: David R. Walt, email: dwalt@ 123456bwh.harvard.edu

          These author contributed equally

          These authors contributed equally

          Article
          ciab465
          10.1093/cid/ciab465
          8241425
          34015087
          f0cb261d-a231-405e-89e5-ae220b4d1cc2
          © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

          This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

          This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

          History
          : 06 April 2021
          Categories
          Brief Report
          AcademicSubjects/MED00290
          Custom metadata
          PAP
          accepted-manuscript

          Infectious disease & Microbiology
          covid-19,mrna vaccine,sars-cov-2 antigens,immune responses,spike
          Infectious disease & Microbiology
          covid-19, mrna vaccine, sars-cov-2 antigens, immune responses, spike

          Comments

          Comment on this article